440 related articles for article (PubMed ID: 22811466)
21. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
22. The experimental study of miRNA in pituitary adenomas.
Liang S; Chen L; Huang H; Zhi D
Turk Neurosurg; 2013; 23(6):721-7. PubMed ID: 24310454
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
24. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2.
Ma Y; Yu S; Zhao W; Lu Z; Chen J
Cancer Lett; 2010 Dec; 298(2):150-8. PubMed ID: 20638779
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
[TBL] [Abstract][Full Text] [Related]
27. Mir-23b and miR-130b expression is downregulated in pituitary adenomas.
Leone V; Langella C; D'Angelo D; Mussnich P; Wierinckx A; Terracciano L; Raverot G; Lachuer J; Rotondi S; Jaffrain-Rea ML; Trouillas J; Fusco A
Mol Cell Endocrinol; 2014 Jun; 390(1-2):1-7. PubMed ID: 24681352
[TBL] [Abstract][Full Text] [Related]
28. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
[TBL] [Abstract][Full Text] [Related]
29. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
Bogner EM; Daly AF; Gulde S; Karhu A; Irmler M; Beckers J; Mohr H; Beckers A; Pellegata NS
Int J Cancer; 2020 Dec; 147(12):3523-3538. PubMed ID: 32856736
[TBL] [Abstract][Full Text] [Related]
30. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
Kasuki Jomori de Pinho L; Vieira Neto L; Armondi Wildemberg LE; Gasparetto EL; Marcondes J; de Almeida Nunes B; Takiya CM; Gadelha MR
Neuroendocrinology; 2011; 94(1):39-48. PubMed ID: 21178332
[TBL] [Abstract][Full Text] [Related]
31. AIP and its interacting partners.
Trivellin G; Korbonits M
J Endocrinol; 2011 Aug; 210(2):137-55. PubMed ID: 21454441
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.
Corbetta S; Vaira V; Guarnieri V; Scillitani A; Eller-Vainicher C; Ferrero S; Vicentini L; Chiodini I; Bisceglia M; Beck-Peccoz P; Bosari S; Spada A
Endocr Relat Cancer; 2010 Mar; 17(1):135-46. PubMed ID: 19926710
[TBL] [Abstract][Full Text] [Related]
33. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-200c inhibits apoptosis in pituitary adenoma cells by targeting the PTEN/Akt signaling pathway.
Liao C; Chen W; Fan X; Jiang X; Qiu L; Chen C; Zhu Y; Wang H
Oncol Res; 2013; 21(3):129-36. PubMed ID: 24512727
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma.
Kong WQ; Bai R; Liu T; Cai CL; Liu M; Li X; Tang H
FEBS J; 2012 Apr; 279(7):1252-60. PubMed ID: 22325466
[TBL] [Abstract][Full Text] [Related]
36. Expression of peptide-23/pancreatitis-associated protein and Reg genes in human pituitary and adenomas: comparison with other fetal and adult human tissues.
Bartoli C; Baeza N; Figarella C; Pellegrini I; Figarella-Branger D
J Clin Endocrinol Metab; 1998 Nov; 83(11):4041-6. PubMed ID: 9814489
[TBL] [Abstract][Full Text] [Related]
37. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
38. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
39. Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
Vierimaa O; Georgitsi M; Lehtonen R; Vahteristo P; Kokko A; Raitila A; Tuppurainen K; Ebeling TM; Salmela PI; Paschke R; Gündogdu S; De Menis E; Mäkinen MJ; Launonen V; Karhu A; Aaltonen LA
Science; 2006 May; 312(5777):1228-30. PubMed ID: 16728643
[TBL] [Abstract][Full Text] [Related]
40. AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling.
Tuominen I; Heliövaara E; Raitila A; Rautiainen MR; Mehine M; Katainen R; Donner I; Aittomäki V; Lehtonen HJ; Ahlsten M; Kivipelto L; Schalin-Jäntti C; Arola J; Hautaniemi S; Karhu A
Oncogene; 2015 Feb; 34(9):1174-84. PubMed ID: 24662816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
